Thursday, March 27, 2025
spot_img

CPS Announces $65.0 Million Securitization of Residual Interests

LAS VEGAS, Nevada, March 20, 2025 (GLOBE NEWSWIRE) — Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced the closing of a $65.0 million securitization of residual interests from previously issued securitizations.

In the transaction, a qualified institutional buyer purchased $65.0 million of asset-backed notes secured by an 80% interest in a CPS majority owned affiliate (“MOA”) that owns the residual interests in five CPS securitizations issued from October 2023 through September 2024.

The MOA interest includes 80% of the amounts on deposit in the underlying spread accounts for each related securitization and 80% of the over-collateralization of each related securitization, which is the difference between the outstanding principal balance of the related receivables less the outstanding principal balance of the notes associated with the securitization. On each monthly payment date, the notes will be paid interest at the coupon rate and, if necessary, a principal payment necessary to maintain a specified minimum collateral ratio.

The transaction was a private offering of securities, not registered under the Securities Act of 1933, or any state securities law. All of such securities having been sold, this announcement of their sale appears as a matter of record only.

About Consumer Portfolio Services, Inc.

Consumer Portfolio Services, Inc. is an independent specialty finance company that provides indirect automobile financing to individuals with past credit problems or limited credit histories. We purchase retail installment sales contracts primarily from franchised automobile dealerships secured by late model used vehicles and, to a lesser extent, new vehicles. We fund these contract purchases on a long-term basis primarily through the securitization markets and service the contracts over their lives.

Investor Relations Contact

Danny Bharwani, EVP/ Chief Financial Officer
949-753-6811

Powered by SlickText.com

Hot this week

Atmus Filtration’s Path To Growth: Analyst Highlights Strong Financials, Tariff Pricing Power

Atmus Filtration Technologies Inc. ATMU has strong growth potential,...

Soleno Shares Are Up Today: What’s Going On?

Soleno Therapeutics, Inc. SLNO shares are trading higher Thursday...

Ultragenyx Stays On JPMorgan’s Focus List As Analyst Highlights Strong Long-Term Positioning

JPMorgan on Thursday shared updated thoughts on Ultragenyx Pharmaceutical Inc’s...

Candel Therapeutics Shares Are Down Today: What’s Going On?

Candel Therapeutics, Inc. CADL shares are are trading lower...

Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug

The Japanese Ministry of Health, Labour and Welfare on...

Topics

Atmus Filtration’s Path To Growth: Analyst Highlights Strong Financials, Tariff Pricing Power

Atmus Filtration Technologies Inc. ATMU has strong growth potential,...

Soleno Shares Are Up Today: What’s Going On?

Soleno Therapeutics, Inc. SLNO shares are trading higher Thursday...

Ultragenyx Stays On JPMorgan’s Focus List As Analyst Highlights Strong Long-Term Positioning

JPMorgan on Thursday shared updated thoughts on Ultragenyx Pharmaceutical Inc’s...

Candel Therapeutics Shares Are Down Today: What’s Going On?

Candel Therapeutics, Inc. CADL shares are are trading lower...

Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug

The Japanese Ministry of Health, Labour and Welfare on...

Chemomab Therapeutics’ Touts Positive Data From Experimental Drug For Chronic Liver Disease

Chemomab Therapeutics Ltd. CMMB on Thursday released results from the...

Vertical Aerospace Unfairly Undervalued, Says Bullish Analyst

D. Boral Capital analyst Jesse Sobelson initiated coverage on...

Petrus Resources Announces Monthly Activity Update

CALGARY, Alberta, March 27, 2025 (GLOBE NEWSWIRE)...
spot_img

Related Articles

Popular Categories

spot_img